Scientists hunt for clues to make Virus-Based infection treatment more effective

NCT ID NCT07076238

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times

Summary

This study is looking for biological markers (biomarkers) that can show whether phage therapy—using viruses that attack bacteria—is working against hard-to-treat lung infections caused by nontuberculous mycobacteria. Researchers will collect blood and airway samples from 100 adults who are being considered for phage therapy as part of their regular care. By comparing samples from those who receive the therapy and those who do not, they hope to find patterns that predict treatment success, such as clearing the infection or improving symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NYU Langone Health

    RECRUITING

    New York, New York, 10016, United States

Conditions

Explore the condition pages connected to this study.